Proper use of drugs

Patients under treatment for sarcoidosis reported adherence issues and would welcome personalized pharmaceutical care: Results from survey online

Cléa Dubrou, Dorian Protzenko, Aurélie S. Leroyer, Raphael Cauchois, Gilles Kaplanski, Guillaume Hache

Social pharmacology

Drugs and patient's dissatisfaction reporting: From a disproportionality pharmacovigilance analysis to social pharmacology

Jean-Louis Montastruc

Letter to editor

Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab

Thomas Darque, Arthur Dubernet, Chloé Martineau, Julia Goossens, Marie-Laure Jullie, Nathalie Sultan

Le numéro 3 de mai - juin 2025 est en ligne

Au sommaire

Clinical pharmacology

Impact of new drug releases on heart failure management and hospitalizations in France: A repeated cross-sectional study between 2014 and 2023

Paul Gautier, Cécile Vindis, Meyer Elbaz, François Montastruc

Clinical research

Évaluation des dépenses du circuit des produits de santé dans le cadre d’études institutionnelles – Étude de cas au CHU de Toulouse

Marie Delon, Pierjan Fourniols, Anabel Saint-Pastou, Geoffrey Bourcier, Audrey Tranier, Laetitia Caturla, Camille Jurado

Pharmacovigilance

COVACPREG, a French prospective cohort study of women vaccinated against COVID-19 during pregnancy

Isabelle Lacroix, Anthony Caillet, Laurane Delteil, Hadjer Ameur, Nassima Padelli, Caroline Hurault-Delarue, Judith Cottin

Effets indésirables de l’association tezacaftor/ivacaftor/elexacaftor pouvant mener à un arrêt de traitement : à propos d’une série de 10 cas

Elora Blaisonneau, Brendan Le Daré, Marion Mercerolle, Astrid Bacle, Louise Triquet, Marie-Noëlle Osmont, Chantal Belleguic, Elisabeth Polard

Retinal vascular occlusion after COVID-19 vaccination: Analysis of the French pharmacovigilance database

Mathilde Beurrier, Jean-Bapiste Conart, Marie Lauren Antoine, Anthony Facile, Haleh Bagheri, Valérie Gras-Champel, Nadine Petitpain

Ischemic cardiopathy induced by capecitabine in gastric cancer: The role of dihydropyrimidine dehydrogenase metabolites

Joaquim Verdaguer, Laurent Chouchana, Marion Robert, Sandrine Bergeron, François Montastruc, Romain Barus

Social pharmacology

Concilier régulation du médicament et démocratie sanitaire : rôle des conseillers patient ou professionnel de santé à l’ANSM

Patrick Maison, Trystan Bacon, Pascale Daynes, Christophe Decoene, Roseline Mazet, Thierry Vial, Stéphane Vignot, Laetitia Belgodère, Wahiba Oualikene-Gonin, Christelle Ratignier-Carbonneil

Therapeutic decision support

Utilisation d’un système d’aide à la décision pharmaceutique dans la valorisation des séjours hospitaliers : évaluation à travers 3 exemples en collaboration avec le département de l’information médicale

Laurine Robert, Ali Laraba, Amélie Bruandet, Alexandra Royer, Pascal Odou, Bertrand Décaudin, Chloé Rousselière

Therapeutic drug monitoring

A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir

Florian Lemaitre, Lidvine Boland, Camille Tron, Matthieu Grégoire, Véronique Lelong-Boulouard, Peggy Gandia, Françoise Goirand, Nicolas Gambier, Christelle Boglione-Kerrien, Bénédicte Franck, Sébastien Lalanne, Arnaud Devresse, Sebastien Briol, Vincent Haufroid, Marie-Clémence Verdier, SFPT Therapeutic Drug Monitoring, Treatment Personalization group (STP-PT) of the French Society of Pharmacology, Therapeutics (SFPT)

Letters to editor

Adagrasib-induced photodistributed hyperpigmentation: Two case reports and pathogenetic hypothesis

Julien Lebled, Jean-Paul Claudel, Marie-Sarah Agier, Laurent Plantier, Bérenger Largeau, Annie-Pierre Jonville-Bera

Dapagliflozin-induced leukocytoclastic vasculitis

Dhouha Sahnoun, Houda Ghardallou, Myriam Agrebi, Mohamed Ben Rejeb, Najet Ghariani, Badreddine Sriha, Mohamed Denguezli, Chaker Ben Salem

Case report of a slow-metabolism of CYP2D6 which led to a misuse of codeine: How can we detect it and how can we take care?

Deborah Montmeat, Xavier Declèves, Laurence Labat, Alicja Puszkiel, Serge Perrot, Anne-Priscille Trouvin

Elexacaftor/tezacaftor/ivacaftor induced liver enzymes abnormalities in breastfed infants: A series of 3 cases

Sandrine Bergeron, Camille Audousset, Gurvan Bourdon, Charles Garabedian, Sophie Gautier

Voxelotor-induced pulmonary embolism

Pauline Schiro, Romain Barus, Laurent Chouchana, Rayane Sari, Pierre Cougoul, François Montastruc, Haleh Bagheri

Oxybutynin induced blindness in a child: Case report

Mouna Daldoul, Ahmed Zaiem, Yasmine Salem Mahjoubi, Ons Charfi, Ghozlane Lakhoua, Sarrah Kastalli, Riadh Daghfous, Imen Aouinti, Sihem El Aidli

Hépatite aiguë cytolytique suivie d’œdèmes associés à l’utilisation des neuroleptiques : à propos d’un cas et revue de la littérature

Fatma Guermazi, Rabeb Jbir, Imen Bouaziz, Rim Atheymen, Dorra Mnif, Nourelhouda Ben Ali, Kamilia Ksouda, Khaled Zghal, Imen Baati, Jawaher Masmoudi

Polyintoxication with cenobamate, perampanel, and carbamazepine: A complex case report

Alexandre Destere, Alexandre O. Gérard, Diane Merino, Elliot Ewig, Fanny Rocher, Nouha Ben Othmann, Benjamin Hennart, Jean Dellamonica, Hervé Hyvernat, Milou-Daniel Drici

Lactulose induced maculo-papular eruption with positive rechallenge: Unusual reaction to this medication

Imen Bouaziz, Rim Atheymen, Khadija Sellami, Rym Sahnoun, Kamilia Ksouda, Emna Bahloul, Hanen Affes, Serria Hammami, Hamida Turki, Khaled Zghal

Adalimumab-induced myoclonus: A potential adverse drug reaction?

Yasmine Salem Mahjoubi, Israa Dahmani, Fatma Zgolli, Widd Kaabi, Sarrah Kastalli, Imen Aouintin, Sihem El Aidli

POUR CONSULTER LES INSTRUCTIONS AUX AUTEURS CLIQUEZ ICI

POUR SOUMETTRE VOS TRAVAUX CLIQUEZ ICI

Clinical pharmacology

Blood glutamate levels in major depression with antidepressants and benzodiazepines: A 6-month prospective cohort study

Khalil El Asmar , Tala El Ghoul, Romain Colle, Rida Assaf, Séverine Martin, Séverine Trabado, Bruno Feve, Céline Verstuyft, Laurent Becquemont, Emmanuelle Corruble

Letters to editor

Preventing shingles starts with vaccinating against chickenpox

Mickaël Rochoy

Rapid desensitization to insulin in a patient with diabetic ketoacidosis and insulin allergy

Emna Chtourou, Fatma Charfi, Imen Chabchoub, Hanen Ghozzi, Ahmed Hakim, Kammoun Thouraya, Khaled Zeghal, Lobna Ben Mahmoud

Subcutaneous rituximab in indolent primary cutaneous B cell lymphoma: A case series of 5 patients with the evaluation of the medico economic impact

Carla Fassanaro, Laurent Mortier, Olivier Carpentier, Inès Arib, Benoit Dervaux, Sarah Faiz

Therapeutic drug monitoring

Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel disease

Zohra Chadli , Ibtissem Hannachi, Nadia Ben Fredj, Hichem Loghmari, Haifa Ben Romdhane, Ahlem Slama, Amel Chaabane, Leila Safer, Karim Aouam

Le numéro 2 de mars avril 2025 est en ligne

Au sommaire : numéro spécial ADDICTOVIGILANCE

sous la coordination de Joelle Micaleff et Maryse Lapeyre-Mestre

Addictovigilance: The edge of reason?

Maryse Lapeyre-Mestre, Joelle Micallef

The French Addictovigilance Network – A multidisciplinary successful journey in the protection of public health

Ana Carmona Araújo 

From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30 years of insight in medication diversion phenomenon in France

Maryse Lapeyre-Mestre, Florence Fabre, Emilie Jouanjus, The French Addictovigilance Network

Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program

Clémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, Hélène Peyrière, Joëlle Micallef 

ASOS, a national monitoring study to assess narcotic prescriptions and indications in France since 2001

Joelle Perri-Plandé, Ghada Miremont-Salamé, Maryse Lapeyre-Mestre, Justine Perino, Valérie Gibaja, Amélie Daveluy 

DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in France

Bruno Revol, Théo Willeman, Marc Manceau, Véronique Dumestre-Toulet, Jean-Michel Gaulier, Alexandra Boucher, Célian Bertin, Hélène Eysseric-Guérin, Nathalie Fouilhé Sam-Laï  for the Compagnie nationale des biologistes et analystes experts (CNBAE), theFrench Addictovigilance Network (FAN)

Inputs of pharmacoepidemiology in addictovigilance: How do they fit together?

Thomas Soeiro, Amélie Daveluy, Caroline Victorri-Vigneau, Maryse Lapeyre-Mestre, Joëlle Micallef 

From regional signal to alert in addictovigilance

Amélie Daveluy, Justine Perino, Valérie Gibaja, Reynald Le Boisselier, Anne Batisse, Ghada Miremont-Salamé, Alexandre Peyré, Alexandra Boucher, Elisabeth Frauger, Joëlle Micallef, Hélène Peyrière

Non-medical nitrous oxide misuse: From identifying a signal to unprecedented addictovigilance network communication

Marylène Guerlais, Sylvie Deheul,FAN: Célian Bertin, Emilie Bouquet, Leila Chouachi, Amélie Daveluy, Céline Eiden, Valérie Gibaja, Emilie Jouanjus, Joëlle Micallef, Bruno Revol

The contribution of addictovigilance data to the French medical cannabis experimentation

Emilie Bouquet, Emilie Jouanjus, Stéphanie Pain, Anne Batisse, Céline Eiden, Cécile Chevallier

Monitoring opioid analgesic misuse, abuse and dependence: What to the data from addictovigilance tell us about the situation in France?

Maryse Lapeyre-Mestre, Celian Bertin, Constança Jalles, Thomas Soeiro, Joëlle Micallef, Anne Roussin